Monitoring long-term effects of SARS-CoV-2 infections
Official title: Long-term Sequelae of Severe Sars-CoV-2 Infections
Run by University of Giessen · NCT04442789 · Data updated 2026-11-12
This study follows patients who were hospitalized with COVID-19 to see how the virus has affected their lungs and heart over the long term.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Giessen Academic / other |
| Locations | 1 site (Giessen) |
| Status | Recruiting |
| Started | May 20, 2020 |
| Main results expected | July 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | March 30, 2025 |
| Trial ID | NCT04442789 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults who have been hospitalized due to a SARS-CoV-2 infection.
✕Probably not a fit
Patients under 18 years of age will not benefit from this study as they are excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational investigation follows patients who have been hospitalized due to SARS-CoV-2 infections to monitor the long-term effects on various organs, particularly focusing on the lungs and cardiovascular system. The study aims to assess the persistence of organ damage and the need for ongoing medical care in these patients. By analyzing the sequelae of COVID-19, the research seeks to understand the broader implications of the virus beyond the acute phase of the infection.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the long-term health impacts of COVID-19, guiding better post-infection care and management strategies.
How similar studies have gone: Other studies have reported on the long-term effects of COVID-19, indicating that this area of research is gaining traction and has shown some success in understanding post-viral sequelae.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * hospitalization due to Sars-CoV-2 infection Exclusion Criteria: * under 18 years of age
Where it's running
-
Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University
Giessen, Germany Recruiting
Study contacts
- Study coordinator: Ulrich Matt, MD, PhD
- Email: ulrich.matt@innere.med.uni-giessen.de
- Phone: 0049-(0)641-985-58773
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Remote Balance in Everyday Life for young MI patients with distress
This study tests a remote 6-session program (rBEL) to help adults under 55 who had a heart attack and feel distressed see if the program and study procedures are feasible.
-
Well-being program for caregivers of patients with advanced heart or lung disease
This study tests an 8-week, home-based wellness program delivered virtually to caregivers of people with advanced cardiac or pulmonary disease to see if it’s feasible and acceptable.
-
Digital diagnosis of newborn heart sounds
This project will test a digital, machine-learning tool that listens to newborn heart sounds to try to detect serious congenital heart problems in the first month of life.
-
Efferon LPS hemoadsorption during and after heart surgery
This trial tests whether using the Efferon® LPS filter during cardiopulmonary bypass and again within 24 hours afterward can lower the chance and severity of multiple organ dysfunction in adults having cardiac surgery who are at higher surgical risk.
-
Comparing preoperative cardiac clearance with the G60 Orthopedic Hip Frailty Index to predict outcomes after hip fracture surgery
This project will test whether preoperative cardiac clearance predicts short-term postoperative mortality better than the G60 Orthopedic Hip Frailty Index for people aged 60 and older who need surgical treatment for hip fractures.
-
Electrical Impedance Tomography for Monitoring Lung Disease
This test tries to see if a painless, noninvasive imaging method called electrical impedance tomography (EIT) can track how air is distributed in the lungs of adults with lung diseases and healthy volunteers and how those results match standard spirometry.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.